The Editor, Eric Rowinsky, and the Associate Editors would like to acknowledge the valuable contributions of the reviewers to the journal. We fully understand the burden and effort that are involved in the reviews and are very grateful for your support. We rely on your expertise to maintain the standards of excellent science for the journal, Investigational New Drugs.
Ghassan Abou-Alfa
Eishi Ashihara
Paul Beavis
Jordan Berlin
Katarzyna Blazewska
Guido Bocci
John Bridgewater
Mans Broekgaarden
Elizabeth Buchbinder
Eric Chen
Qi Chen
Belamy Cheung
K.N. Chi
Gabriela Chiorean
Roger Cohen
Natalie Cook
Luciana Corrêa
Simon Crabb
Suman Dasgupta
Miranda de Jager
R. Donald Harvey
Dong-Jun Fu
Daichi Fujimoto
Weimin Gao
Beppe Giaccone
Sharlene Gill
M. Concepción Gimeno
Milena Gusella
Akinobu Hamada
Petra Heffeter
Howard Hochster
Satoshi Igawa
Hisao Imai
Rao Jaladanki
Li Jing
Nenad Joksimović
Subash C. Jonnalagadda
Masahi Kanai
Christos Kyriakopoulos
Rosamaria Lappano
Ismael Lares-Asseff
Chia-Chi (Josh) Lin
Jun Liu
Zhiqiang Liu
Jon Loree
Hideki Maeda
Stephen Mathew
Hans Minderman
Olivier Mir
Elena Morosova
Sumimasa Nagai
Pollyanna Oliveira
E.M. O’Reilly
Brian Piper
Alessandro Poggi
Edvin Pozharskiy
Antonino Puglisi
Qi Qi
Aramandla Ramesh
Mark Ratain
Stephan Joel Reshkin
Vincent Ribrag
Oliver Sartor
Tarah Satoh
Michael Sawyer
Sarah Schott
Desh Deepak Singh
Anatoly Skalny
John Spencer
Mitsukuni Suenaga
Masayuki Takeda
Motohiro Tamiya
Tsuimin Tsai
Chris Twelves
Ulka Vaishampayan
Hui-Chun Wang
Harvey Wong
Liu Wukun
Dmitry Zhdanov
Zongjian Zhu
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Acknowledgement of Reviewers 2018. Invest New Drugs 37, 199 (2019). https://doi.org/10.1007/s10637-019-00729-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-019-00729-z